In August 2017, Thermo Fisher Scientific completed the acquisition of Patheon, creating the world’s most comprehensive and sophisticated end-to-end CDMO partner. One year later, Thermo Fisher’s Pharma Services is delivering integrated drug development and clinical trial services to clients across the globe. In this webinar, Thermo Fisher senior executives Franco Negron and Leon Wyszkowski provide an inside view of how Pharma Services is redefining outsourced biopharmaceutical services.
Attendees who are interested in M&A, drug development, and clinical outsourcing will gain the following insights from the webinar:
- The status of the integration of Patheon into Thermo Fisher Scientific.
- An introduction to Thermo Fisher’s Pharma Services.
- The unified operational and business strategy established to deliver manufacturing and clinical services to clients.
- A forward-looking view of the evolution of outsourced pharmaceutical services.
- An open question and answer segment.